1. Home
  2. RGLD vs NBIX Comparison

RGLD vs NBIX Comparison

Compare RGLD & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royal Gold Inc.

RGLD

Royal Gold Inc.

HOLD

Current Price

$209.32

Market Cap

17.0B

Sector

Industrials

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$155.13

Market Cap

14.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGLD
NBIX
Founded
1981
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.0B
14.4B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
RGLD
NBIX
Price
$209.32
$155.13
Analyst Decision
Buy
Strong Buy
Analyst Count
8
19
Target Price
$213.38
$174.84
AVG Volume (30 Days)
726.8K
924.1K
Earning Date
11-05-2025
10-28-2025
Dividend Yield
0.86%
N/A
EPS Growth
66.97
12.44
EPS
7.28
4.19
Revenue
$849,255,000.00
$2,682,700,000.00
Revenue This Year
$25.73
$23.76
Revenue Next Year
$64.70
$18.01
P/E Ratio
$28.77
$37.13
Revenue Growth
28.17
19.61
52 Week Low
$130.67
$84.23
52 Week High
$209.43
$160.18

Technical Indicators

Market Signals
Indicator
RGLD
NBIX
Relative Strength Index (RSI) 66.72 62.66
Support Level $198.14 $150.26
Resistance Level $207.66 $160.18
Average True Range (ATR) 5.69 4.25
MACD 1.21 0.76
Stochastic Oscillator 98.87 74.77

Price Performance

Historical Comparison
RGLD
NBIX

About RGLD Royal Gold Inc.

Royal Gold Inc enquires and manages precious metal royalties and streams with a focus on gold. The company purchases a percentage of the metal produced from a mineral property for an initial payment without assuming responsibility for mining operations. Similarly, precious metal streams are purchase agreements with mine operators providing the right to purchase all or a portion of one or more metals produced from a mine in exchange for an upfront deposit payment. Generally, Royal Gold does not work on the properties in which it holds royalty and streaming assets. The company owns a portfolio of producing, development, evaluation, and exploration royalties and streams, and the majority of group revenue is generated from Canada, Mexico, Chile, and the United States.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: